IHT Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.01M | Buy |
18,275
+3,265
| +22% | +$177K | 0.02% | 573 |
|
|
2025
Q4 | $736K | Buy |
15,010
+188
| +1% | +$8.77K | 0.02% | 633 |
|
|
2025
Q3 | $640K | Buy |
14,822
+86
| +0.6% | +$3.36K | 0.02% | 662 |
|
|
2025
Q2 | $566K | Buy |
14,736
+1,589
| +12% | +$60.7K | 0.02% | 657 |
|
|
2025
Q1 | $509K | Buy |
13,147
+42
| +0.3% | +$1.54K | 0.02% | 664 |
|
|
2024
Q4 | $443K | Sell |
13,105
-11,824
| -47% | -$426K | 0.01% | 719 |
|
|
2024
Q3 | $1.01M | Buy |
24,929
+8,266
| +50% | +$338K | 0.03% | 497 |
|
|
2024
Q2 | $642K | Sell |
16,663
-959
| -5% | -$40.3K | 0.02% | 560 |
|
|
2024
Q1 | $755K | Buy |
17,622
+5,824
| +49% | +$240K | 0.03% | 502 |
|
|
2023
Q4 | $437K | Buy |
11,798
+589
| +5% | +$21.1K | 0.02% | 642 |
|
|
2023
Q3 | $406K | Buy |
11,209
+3,171
| +39% | +$113K | 0.02% | 620 |
|
|
2023
Q2 | $286K | Sell |
8,038
-2,841
| -26% | -$102K | 0.01% | 745 |
|
|
2023
Q1 | $387K | Buy |
10,879
+1,949
| +22% | +$68.2K | 0.02% | 603 |
|
|
2022
Q4 | $314K | Sell |
8,930
-5,157
| -37% | -$172K | 0.02% | 646 |
|
|
2022
Q3 | $415K | Buy |
14,087
+4,229
| +43% | +$160K | 0.03% | 512 |
|
|
2022
Q2 | $536K | Buy |
9,858
+62
| +0.6% | +$3.42K | 0.05% | 375 |
|
|
2022
Q1 | $533K | Buy |
9,796
+1,193
| +14% | +$64.8K | 0.04% | 393 |
|
|
2021
Q4 | $474K | Buy |
8,603
+61
| +0.7% | +$3.17K | 0.03% | 457 |
|
|
2021
Q3 | $408K | Sell |
8,542
-5,772
| -40% | -$290K | 0.03% | 494 |
|
|
2021
Q2 | $713K | Buy |
14,314
+1,099
| +8% | +$52.8K | 0.05% | 410 |
|
|
2021
Q1 | $590K | Buy |
13,215
+1,885
| +17% | +$85.6K | 0.04% | 397 |
|
|
2020
Q4 | $521K | Sell |
11,330
-1,560
| -12% | -$71.7K | 0.04% | 396 |
|
|
2020
Q3 | $606K | Buy |
12,890
+3,152
| +32% | +$158K | 0.06% | 301 |
|
|
2020
Q2 | $496K | Sell |
9,738
-7,316
| -43% | -$375K | 0.07% | 293 |
|
|
2020
Q1 | $808K | Sell |
17,054
-764
| -4% | -$40.8K | 0.12% | 191 |
|
|
2019
Q4 | $1.05M | Buy |
17,818
+1,561
| +10% | +$86.8K | 0.12% | 189 |
|
|
2019
Q3 | $869K | Buy |
16,257
+6,729
| +71% | +$346K | 0.12% | 199 |
|
|
2019
Q2 | $477K | Sell |
9,528
-977
| -9% | -$49K | 0.07% | 295 |
|
|
2019
Q1 | $549K | Sell |
10,505
-3,495
| -25% | -$175K | 0.09% | 249 |
|
|
2018
Q4 | $669K | Buy |
14,000
+2,222
| +19% | +$109K | 0.13% | 192 |
|
|
2018
Q3 | $591K | Buy |
11,778
+929
| +9% | +$47.2K | 0.13% | 200 |
|
|
2018
Q2 | $547K | Buy |
10,849
+3,656
| +51% | +$184K | 0.14% | 195 |
|
|
2018
Q1 | $349K | Sell |
7,193
-1,105
| -13% | -$51.5K | 0.09% | 244 |
|
|
2017
Q4 | $388K | Buy |
8,298
+1,157
| +16% | +$53.4K | 0.1% | 243 |
|
|
2017
Q3 | $362K | Sell |
7,141
-97
| -1% | -$4.92K | 0.15% | 157 |
|
|
2017
Q2 | $2 | Buy |
7,238
+2,512
| +53% | +$134K | ﹤0.01% | 1221 |
|
|
2017
Q1 | $248K | Buy |
4,726
+846
| +22% | +$42.9K | 0.17% | 150 |
|
|
2016
Q4 | $188K | Buy |
+3,880
| New | +$192K | 0.14% | 170 |
|
Other funds holding GSK
JEST
IHT Wealth Management's GSK Position: Q1 2026 in Review
IHT Wealth Management increased its GSK (GSK) stake by 22% in Q1 2026, buying an estimated $177K and bringing the position to 18,275 shares worth $1.01M. The position accounts for 0.02% of the portfolio, ranked #573.
IHT Wealth Management first reported a position in GSK in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.05M in Q4 2019. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- IHT Wealth Management held 18,275 shares of GSK worth $1.01M as of Q1 2026.
- IHT Wealth Management bought 3,265 GSK shares in Q1 2026, an estimated $177K.
- GSK made up 0.02% of IHT Wealth Management's portfolio in Q1 2026, its #573 holding.
- IHT Wealth Management first reported a position in GSK in Q4 2016 and has held it in 38 quarters since.
- IHT Wealth Management's GSK position peaked at $1.05M in Q4 2019.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on IHT Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.